UPCOMING EXHIBITIONS
SLAS2015
February 7 - 11, 2015
Washington, DC
Booth: #1619
Exhibitor Tutorial: Tuesday, February 10th from 2 – 2:45pm in room 143c.
Conformation-Sensitive Assay Detection for Accelerated Drug Discovery Research
Learn about the superior analytical power of TruBind™ Back Scattering Interferometry (BSI) technology for molecular interaction studies.
TruBind BSI technology offers significant advantages over conventional methods by providing direct binding Kd determinations and confirming target engagement by leveraging label-free, conformation-sensitive detection. Designed to analyze complex and intractable drug targets maintained in native or native-like environments, this technology platform is ideal for studying allosteric kinases and GPCR’s as membrane preps, solubilized proteins, nanodiscs or amphipols, Ion Channels, RTK’s, Allosteric Contractile Proteins, Tau and Alpha Synuclein Fibrils, Transcription Factors, and Transporter Proteins.
Molecular Sensing’s tutorial begins with a brief review of the science and technology fundamentals and then proceeds to a detailed discussion of the direct application of TruBind BSI technology to a variety of challenging targets. Come learn about TruBind Assay Services and the TruBind 100 System to see how BSI technology can accelerate your drug discovery research.
Drug Discovery Chemistry 2015
April 21 - 23, 2015
San Diego, CA
Booth: #15
Seminar: “Binding studies of Type I, II and III kinase inhibitors against Bcr-Abl kinase using Back-Scattering Interferometry” presented by Scot R. Weinberger, EVP Molecular Sensing, Inc. The presentation will occur during the Kinase Inhibitor Chemistry track on Wednesday, April 22 from 3:10 – 3:40pm.
GO TO EVENT WEBSITE >
World Pre-Clinical Congress: Targeting GPCR’s
June 10 - 12, 2015
Boston, MA
Booth: #19
Seminar: “A label-free, solution-based affinity assay for allosteric GPCR ligand binding using Back-Scattering Interferometry” presented by Richard J. Isaacs, PhD, Molecular Sensing, Inc. The presentation will occur during the Targeting GPCR’s track on Wednesday, June 10 from 3:35 – 4:05pm.
GO TO EVENT WEBSITE >
PAST EXHIBITIONS
ELRIG: Drug Discovery 2014
Manchester, UK
September 2 & 3
Booth # F6
Feature: Introduction of the TruBind™ BSI System and Assay Services
Poster presentation: Novel GPR39 Agonists: Correlation of binding affinity using label-free Back Scattering Interferometry with potency in functional assays.
Industry Presentation:
The use of Backscattering Interferometry to Investigate Positive Allosteric Modulators of the M4 Receptor
3-September-2014, at 15:00
Presented by Dr. Jon Ellery, Principal Scientist, Takeda Cambridge, Ltd.
MipTec 2014
Basel, Switzerland
September 23 - 25
Booth # A52
Features: Introduction of the TruBind™ BSI System and Assay Services
Poster presentation: Yes. Title forthcoming
Industry Symposium:
Back-Scattering Interferometry: A New Era In Label-Free, Conformation Sensitive Molecular Interaction Assay Technology for Drug discovery
25th September, 12:30 – 13:30
Presented by Scot Weinberger, Co-founder of MSI, EVP of R&D
The MSI MipTech Industry Symposium will present the enabling analytical power of Back-Scattering Interferometry (BSI) as applied to molecular interaction studies in drug discovery research. BSI provides direct binding Kd determinations with label-free, conformation-sensitive detection. BSI delivers significant advantages over conventional methods for complex and intractable drug targets maintained in native or native-like environments, including: allosteric kinases and GPCR’s as membrane preps, solubilized proteins, nanodiscs or amphipols; Ion Channels; RTK’s; Allosteric Contractile Proteins; Tau and Alpha Synuclein Fibrils; Transcription Factors; and Transporter Proteins.
The Symposium begins with a review of BSI theory and fundamentals and then proceeds to discuss the direct application of BSI technology to a variety of challenging targets including: GPCR’s, contractile proteins, kinases, and fibrils. Molecular Sensing will introduce its TruBind™ Assay Services and TruBind 100 automated BSI system. An interactive question and answer format will be utilized throughout the course of the symposium.
Discovery on Target 2014
Boston, MA, USA
October 8 - 10
Booth # 23
Feature: Introduction of the TruBind™ BSI System and Assay Services
Poster presentation: Novel GPR39 Agonists: Correlation of binding affinity using label-free Back Scattering Interferometry with potency in functional assays.
Industry Presentation:
The use of Backscattering Interferometry to Investigate Positive Allosteric Modulators of the M4 Receptor
October 9 at 9:10 am in the New Approaches to Studying GPCR’s session
Presented by Dr. Jon Ellery, Principal Scientist, Takeda Cambridge, Ltd.